28 November 2011
10.15 am -12.15 pm - Mon Dec 5th 2011 - Marriot Grand Ballroom Salon G
ASTMH 2011 annual meeting - Philadelphia, USA
Symposium description:
Artemisinin-based Combination Treatments (ACTs) for malaria have been widely deployed in Africa. Reassuring safety profiles have been documented in randomised controlled trials, but individual studies are usually insufficiently powered to detect rare or unknown side effects, do not evaluate the safety of multiple ACT courses in individuals and exclude specific groups such as women in pregnancy or those with underlying medical conditions. Routine pharmacovigilance systems are underpowered in most settings to evaluate the safety of drugs when deployed at scale. This symposium brings together several of the initiatives currently working to address these deficiencies and to consolidate the safety profile of ACTs.
Symposium objectives:
Symposium Programme:
Chairs: David Schellenberg, LSHTM, and Patrick Kachur, CDC
10.15 AM - Assessing safety in pregnancy; the approach of the Malaria in Pregnancy Consortium - Esperança Sevene, Malaria in Pregnancy Consortium & Eduardo Mondlane University/Manhiça Foundation, Maputo, Mozambique
10.35 AM - Evaluating the safety of ACTs in practice: the structure and function of a new safety repository - Cheryl Pace, ACT Consortium & Liverpool School of Tropical Medicine, Liverpool, UK
10.55 AM - INESS Platform: Health systems dynamics and pharmacovigilance in sub-Saharan Africa - Fred Binka, INESS, University of Ghana School of Public Health, Accra, Ghana
11.15 AM - Technological innovations for better health delivery in resource constrained settings: linking household data to health facility data - Honorati Masanja, Ifakara Health Institute, Dar es Salaam, Tanzania
11.35 AM - Evaluating the safety of anti-malarial drugs and vaccines in Africa; a WHO perspective - Alex Dodoo, WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, University of Ghana Medical School, Accra, Ghana